跳至主要内容
临床试验/CTRI/2024/11/076685
CTRI/2024/11/076685尚未招募4 期

Proof-of-concept clinical study to evaluate the stain removal efficacy of a commercially available as compared to negative control toothpaste

Colgate-Palmolive1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年11月16日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Changes in Tooth stain determined by examiner use Lobene Stain

研究概览

简要总结

This is a proof-of-concept clinical study to evaluate the stain removal efficacy of a commercially available toothpaste as compared to negative control toothpaste. Thirty (30) subjects, aged 18-70 years, inclusive, will be entered into the study. Candidates who have expressed an interest in participating will be selected based on the inclusion and exclusion criteria. This is a Phase IV, single-center, two cell, parallel-group and double-blinded clinical study.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Outcome Assessor Blinded

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Potential subjects must meet ALL of the following criteria: Signed Informed Consent Form; Male and female subjects aged 18-70 years, inclusive; Good general health and good oral health based on the opinion of the study investigator; Present twelve (12) scorable natural anterior teeth (free of large restorations or prosthetics).
  • Availability for the duration of the study; Self reported consumption of tea, coffee or tobacco ≥ 2 times a day.
  • A minimum mean Composite Lobene Index score of 1 or greater.
  • Clinical evidence of a tendency to form stains on anterior teeth.

排除标准

  • Potential subjects must NOT HAVE ANY of the following conditions: Presence of orthodontic appliances or any anterior tooth with a prosthetic crown or veneer.
  • Presence of partial removable dentures.
  • Tumors or significant pathology of the soft or hard tissues of the oral cavity.
  • Presence of anterior teeth with severe or atypical staining, which include tetracycline or hypo-calcification.
  • Use of antibiotics or stain inducing medications any time during the one month prior to entry into the study.
  • Dental prophylaxis received in the past four weeks prior to baseline examinations or usage of whitening toothpaste.
  • History of alcohol or drug abuse.
  • Exposed to a tooth whitening procedure during the last 3 months.
  • Moderate periodontal disease (purulent exudate, tooth mobility, and/or extensive loss of periodontal attachment or alveolar bone) or any other condition that the dental examiner considers would exclude you from participation.
  • Five or more carious lesions requiring immediate restorative treatment.
  • History of allergy to consumer or personal care products as determined by the dental professional monitoring the study.
  • Participation in any other clinical study or test panel within the 30-day period prior to entering into the study.
  • Pregnant women or women who are breast-feeding.
  • Medical conditions that the investigator considers significant which may compromise the subject’s safety as well as the quality of the study results.
  • Restorations on the teeth to be scored which may interfere with scoring procedures.

结局指标

主要结局

Changes in Tooth stain determined by examiner use Lobene Stain

时间窗: Baseline, 7 days and 14 days

次要结局

  • N/A(N/A)

研究者

发起方
Colgate-Palmolive
申办方类型
Other [FMCG - Global]
责任方
Principal Investigator
主要研究者

Dr Bhuvana Gurumurthy

Colgate-Palmolive India Limited

研究点 (1)

Loading locations...

相似试验

Efficacy of a whitening vs non-whitening toothpaste... | 临床试验